Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Human CRMP4 mutation and disrupted Crmp4 expression in mice are associated with ASD characteristics and sexual dimorphism.

Tsutiya A, Nakano Y, Hansen-Kiss E, Kelly B, Nishihara M, Goshima Y, Corsmeier D, White P, Herman GE, Ohtani-Kaneko R.

Sci Rep. 2017 Dec 1;7(1):16812. doi: 10.1038/s41598-017-16782-8.

2.

Deficiency of a brain-specific chemokine-like molecule, SAM3, induces cardinal phenotypes of autism spectrum disorders in mice.

Kim S, Lee B, Choi JH, Kim JH, Kim CH, Shin HS.

Sci Rep. 2017 Nov 28;7(1):16503. doi: 10.1038/s41598-017-16769-5.

3.

Neural Hyperexcitability in Autism Spectrum Disorders.

Takarae Y, Sweeney J.

Brain Sci. 2017 Oct 13;7(10). pii: E129. doi: 10.3390/brainsci7100129. Review.

4.

Maturation, Refinement, and Serotonergic Modulation of Cerebellar Cortical Circuits in Normal Development and in Murine Models of Autism.

Hoxha E, Lippiello P, Scelfo B, Tempia F, Ghirardi M, Miniaci MC.

Neural Plast. 2017;2017:6595740. doi: 10.1155/2017/6595740. Epub 2017 Aug 15. Review.

5.

Integrative Analysis of Brain Region-specific Shank3 Interactomes for Understanding the Heterogeneity of Neuronal Pathophysiology Related to SHANK3 Mutations.

Lee Y, Kang H, Lee B, Zhang Y, Kim Y, Kim S, Kim WK, Han K.

Front Mol Neurosci. 2017 Apr 19;10:110. doi: 10.3389/fnmol.2017.00110. eCollection 2017.

6.

Zinc deficiency and low enterocyte zinc transporter expression in human patients with autism related mutations in SHANK3.

Pfaender S, Sauer AK, Hagmeyer S, Mangus K, Linta L, Liebau S, Bockmann J, Huguet G, Bourgeron T, Boeckers TM, Grabrucker AM.

Sci Rep. 2017 Mar 27;7:45190. doi: 10.1038/srep45190.

7.

Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders.

Torres VI, Vallejo D, Inestrosa NC.

Neural Plast. 2017;2017:8081758. doi: 10.1155/2017/8081758. Epub 2017 Feb 26. Review.

8.

A critical role of spinal Shank2 proteins in NMDA-induced pain hypersensitivity.

Yoon SY, Kwon SG, Kim YH, Yeo JH, Ko HG, Roh DH, Kaang BK, Beitz AJ, Lee JH, Oh SB.

Mol Pain. 2017 Jan;13:1744806916688902. doi: 10.1177/1744806916688902.

9.

SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras.

Lilja J, Zacharchenko T, Georgiadou M, Jacquemet G, De Franceschi N, Peuhu E, Hamidi H, Pouwels J, Martens V, Nia FH, Beifuss M, Boeckers T, Kreienkamp HJ, Barsukov IL, Ivaska J.

Nat Cell Biol. 2017 Apr;19(4):292-305. doi: 10.1038/ncb3487. Epub 2017 Mar 6.

10.

Proteomic Analysis of Post-synaptic Density Fractions from Shank3 Mutant Mice Reveals Brain Region Specific Changes Relevant to Autism Spectrum Disorder.

Reim D, Distler U, Halbedl S, Verpelli C, Sala C, Bockmann J, Tenzer S, Boeckers TM, Schmeisser MJ.

Front Mol Neurosci. 2017 Feb 14;10:26. doi: 10.3389/fnmol.2017.00026. eCollection 2017.

11.

Cry, baby, cry: Expression of Distress as a Biomarker and Modulator in Autism Spectrum Disorder.

Esposito G, Hiroi N, Scattoni ML.

Int J Neuropsychopharmacol. 2017 Feb 15. doi: 10.1093/ijnp/pyx014. [Epub ahead of print] No abstract available.

12.

Oxytocin improves behavioral and electrophysiological deficits in a novel Shank3-deficient rat.

Harony-Nicolas H, Kay M, Hoffmann JD, Klein ME, Bozdagi-Gunal O, Riad M, Daskalakis NP, Sonar S, Castillo PE, Hof PR, Shapiro ML, Baxter MG, Wagner S, Buxbaum JD.

Elife. 2017 Jan 31;6. pii: e18904. doi: 10.7554/eLife.18904.

13.

Current Perspectives in Autism Spectrum Disorder: From Genes to Therapy.

Chahrour M, O'Roak BJ, Santini E, Samaco RC, Kleiman RJ, Manzini MC.

J Neurosci. 2016 Nov 9;36(45):11402-11410. Review.

14.

Actin-Dependent Alterations of Dendritic Spine Morphology in Shankopathies.

Sarowar T, Grabrucker AM.

Neural Plast. 2016;2016:8051861. Epub 2016 Oct 4. Review.

15.

The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia.

Crider A, Pillai A.

Curr Behav Neurosci Rep. 2016 Jun;3(2):154-164. Epub 2016 Apr 16.

16.

Altered nocifensive behavior in animal models of autism spectrum disorder: The role of the nicotinic cholinergic system.

Wang L, Almeida LE, Nettleton M, Khaibullina A, Albani S, Kamimura S, Nouraie M, Quezado ZM.

Neuropharmacology. 2016 Dec;111:323-334. doi: 10.1016/j.neuropharm.2016.09.013. Epub 2016 Sep 13.

17.

Dysfunctional cerebellar Purkinje cells contribute to autism-like behaviour in Shank2-deficient mice.

Peter S, Ten Brinke MM, Stedehouder J, Reinelt CM, Wu B, Zhou H, Zhou K, Boele HJ, Kushner SA, Lee MG, Schmeisser MJ, Boeckers TM, Schonewille M, Hoebeek FE, De Zeeuw CI.

Nat Commun. 2016 Sep 1;7:12627. doi: 10.1038/ncomms12627.

18.

The SocioBox: A Novel Paradigm to Assess Complex Social Recognition in Male Mice.

Krueger-Burg D, Winkler D, Mitkovski M, Daher F, Ronnenberg A, Schlüter OM, Dere E, Ehrenreich H.

Front Behav Neurosci. 2016 Aug 11;10:151. doi: 10.3389/fnbeh.2016.00151. eCollection 2016.

19.

Neurophysiological hyperresponsivity to sensory input in autism spectrum disorders.

Takarae Y, Sablich SR, White SP, Sweeney JA.

J Neurodev Disord. 2016 Aug 8;8:29. doi: 10.1186/s11689-016-9162-9. eCollection 2016.

20.

Novel Shank3 mutant exhibits behaviors with face validity for autism and altered striatal and hippocampal function.

Jaramillo TC, Speed HE, Xuan Z, Reimers JM, Escamilla CO, Weaver TP, Liu S, Filonova I, Powell CM.

Autism Res. 2017 Jan;10(1):42-65. doi: 10.1002/aur.1664. Epub 2016 Aug 5.

PMID:
27492494

Supplemental Content

Support Center